KRF’s Founder and CEO Phil Wolfson MD
Phil Wolfson MD was Principal Investigator for the MAPS sponsored Phase 2, FDA approved 18-person study of MDMA Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine Assisted Psychotherapy. Phil’s book The Ketamine Papers has been published by MAPS and is the seminal work in the burgeoning ketamine arena.
Phil is a sixties activist, psychiatrist/psychotherapist, writer, practicing Buddhist and psychonaut who has lived in the Bay Area for 38 years. He is the author of Noe – A Father/Son Song of Love, Life, Illness and Death (2011, North Atlantic Books). In the 1980s, he participated in clinical research with MDMA (Ecstasy). He has been awarded five patents for unique herbal medicines. He is a journalist and author of numerous articles on politics, transformation, psychedelics, consciousness and spirit, and was a founding member of the Heffter Research Institute. Phil has taught in the graduate psychology programs at JFK University, CIIS and the UCSF School of Medicine Department of Psychiatry.
Phil is the founder and CEO of KRF and is committed to making the organization a vibrant contributor to the betterment of human beings through psychedelic psychotherapy.
Phil is dedicated to the development and practice of humanized, expansive, and compassionate psychotherapy, supported by 50 years of deep clinical experience in psychiatry, psychotherapy, and alternative medicines.
He’s been the Director of an alternative hospital in the public sector, a leader in psychedelic psychotherapy and research since the 1980’s, and the principal proponent of KAP. He has published many studies including the seminal book The Ketamine Papers.
Widely featured in The New Yorker, Vanity Fair, SF Chronicle, and Wired, alongside numerous podcasts, lectures, and presentations, Phil has devoted himself to assisting those who suffer with loss and bereavement.